These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1155384)
21. Stable isotope labelling and FPLC-ICP-SFMS for the accurate determination of clinical iron status parameters in human serum. del Castillo Busto ME; Montes-Bayón M; Bettmer J; Sanz-Medel A Analyst; 2008 Mar; 133(3):379-84. PubMed ID: 18299753 [TBL] [Abstract][Full Text] [Related]
22. [II. Determination of unsaturated iron binding capacity (UIBC) using an isotopic method]. Nyssen M; Bizollon CA; Dorche J Ann Biol Clin (Paris); 1973; 31(4):275-82. PubMed ID: 4723408 [No Abstract] [Full Text] [Related]
23. Terbium chelation, a specific fluorescent tagging of human transferrin. Optimization of conditions in view of its application to the HPLC analysis of carbohydrate-deficient transferrin (CDT). Nicotra S; Sorio D; Filippi G; De Gioia L; Paterlini V; De Palo EF; Grandori R; Tagliaro F; Santambrogio C Anal Bioanal Chem; 2017 Nov; 409(28):6605-6612. PubMed ID: 28971232 [TBL] [Abstract][Full Text] [Related]
24. Fluorimetric determination of febuxostat in dosage forms and in real human plasma via Förster resonance energy transfer. El-Gizawy SM; Atia NN; Hosny NM Luminescence; 2018 Aug; 33(5):877-884. PubMed ID: 29687589 [TBL] [Abstract][Full Text] [Related]
25. The fluorimetric determination of transferrin in blood serum. Miller JM; Thirkettle C Biochem Med; 1975 May; 13(1):98-100. PubMed ID: 1167171 [No Abstract] [Full Text] [Related]
26. A mass spectrometric and molecular modelling study of cisplatin binding to transferrin. Khalaila I; Allardyce CS; Verma CS; Dyson PJ Chembiochem; 2005 Oct; 6(10):1788-95. PubMed ID: 16196027 [TBL] [Abstract][Full Text] [Related]
27. Total iron binding capacity and transferrin concentration in the assessment of iron status. Kasvosve I; Delanghe J Clin Chem Lab Med; 2002 Oct; 40(10):1014-8. PubMed ID: 12476940 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of Tb3+ fluoresence induced by serum proteins other than apotransferrin. Romslo I Clin Chim Acta; 1977 Feb; 75(1):171-4. PubMed ID: 66108 [TBL] [Abstract][Full Text] [Related]
29. Structural and functional characterization of recombinant human serum transferrin secreted from Pichia pastoris. Mizutani K; Hashimoto K; Takahashi N; Hirose M; Aibara S; Mikami B Biosci Biotechnol Biochem; 2010; 74(2):309-15. PubMed ID: 20139607 [TBL] [Abstract][Full Text] [Related]
30. Interference of deferasirox with assays for serum iron and serum unsaturated iron binding capacity during iron chelating therapy. Ikuta K; Ito S; Tanaka H; Sasaki K; Torimoto Y; Fujiya M; Kohgo Y Clin Chim Acta; 2011 Nov; 412(23-24):2261-6. PubMed ID: 21884685 [TBL] [Abstract][Full Text] [Related]
31. Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex. Sakajiri T; Yamamura T; Kikuchi T; Ichimura K; Sawada T; Yajima H Biol Trace Elem Res; 2010 Sep; 136(3):279-86. PubMed ID: 19859668 [TBL] [Abstract][Full Text] [Related]
32. An Improved Method for Quick Quantification of Unsaturated Transferrin. Guo R; Gao J; Hui L; Li Y; Liu J; Fu Y; Shi L; Wang Y; Liu B Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140091 [TBL] [Abstract][Full Text] [Related]
33. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis. Hickman PE; Hourigan LF; Powell LW; Cordingley F; Dimeski G; Ormiston B; Shaw J; Ferguson W; Johnson M; Ascough J; McDonell K; Pink A; Crawford DH Gut; 2000 Mar; 46(3):405-9. PubMed ID: 10673305 [TBL] [Abstract][Full Text] [Related]
34. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893 [TBL] [Abstract][Full Text] [Related]
35. Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins. Farnaud S; Amini M; Rapisarda C; Cammack R; Bui T; Drake A; Evans RW; Suryo Rahmanto Y; Richardson DR Int J Biochem Cell Biol; 2008; 40(12):2739-45. PubMed ID: 18691669 [TBL] [Abstract][Full Text] [Related]
36. The effect of a low-protein diet on serum levels of ceruloplasmin and transferrin in patients with chronic renal failure. Marecek Z; Vulterinová M; Skála I; Pechar J; Doberský P; Schück O; Nádvorníková H; Heyrovský I Clin Nephrol; 1978 Jan; 9(1):38-40. PubMed ID: 630743 [TBL] [Abstract][Full Text] [Related]
37. Factors affecting the serum iron-binding capacity in the elderly. Awad MO; Barford AV; Grindulis KA; Montgomery RD; Sammons HG Gerontology; 1982; 28(2):125-31. PubMed ID: 7084678 [TBL] [Abstract][Full Text] [Related]
38. Intrinsic fluorescence reports a global conformational change in the N-lobe of human serum transferrin following iron release. James NG; Berger CL; Byrne SL; Smith VC; MacGillivray RT; Mason AB Biochemistry; 2007 Sep; 46(37):10603-11. PubMed ID: 17711300 [TBL] [Abstract][Full Text] [Related]
39. Spectral and metal-binding properties of three single-point tryptophan mutants of the human transferrin N-lobe. He QY; Mason AB; Lyons BA; Tam BM; Nguyen V; MacGillivray RT; Woodworth RC Biochem J; 2001 Mar; 354(Pt 2):423-9. PubMed ID: 11171122 [TBL] [Abstract][Full Text] [Related]
40. Fluorescence assay of non-transferrin-bound iron in thalassemic sera using bacterial siderophore. Sharma M; Saxena R; Gohil NK Anal Biochem; 2009 Nov; 394(2):186-91. PubMed ID: 19632191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]